Sanofi SA at JPMorgan Healthcare Conference Transcript
Good morning. It's my pleasure to welcome Sanofi to the JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst. And from Sanofi. I have standing next to me Paul Hudson, the CEO of Sanofi.
Before I hand over to Paul, I'd just remind everybody that the breakout session is in the Borgia Room at the back.
Paul, welcome to the conference.
Thank you. Thank you, Richard. Thank you, everybody, and good morning. Delighted to be here. Delighted to be representing the company.
So the normal comments on forward-looking statements.
Okay. So let's cut to it. So the plan we have at Sanofi is a bold one, it's an exciting one. The work starts now, but the benefits really materialize over 2 phases.
Firstly, and up front, we're refocusing the organization. We're working hard on making some tough decisions. And we're doing that in pursuit of an increased top line performance and increased
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |